Since this analysis included features detected post SMA-diagnosis, the determination of whether a phenotype is an independent feature of SMA, directly attributable to reduced SMN levels, or simply a consequence of neuromuscular dysfunction is unclear. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.